Singhvi Rahul (CIK 1322731) reported 2 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-11-26). Recent activity: Buy KAPA (19,084 shares), Buy CDXS (40,983 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-26 | Kairos Pharma, LTD. (KAPA) | Director | Buy | 19,084 | $0 |
| 2025-06-12 | CODEXIS, INC. (CDXS) | Director | Buy | 40,983 | $0 |
Source: SEC Form 4 filings · as of 2025-11-26